InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (2 ops.)
Insider track record
Board DirectorDisclosed buys
0
Disclosed sells
2
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the complete record of transactions filed by Scots-Knight Denise, Director. Insider active across 2 companies, notably Elanco Animal Health Inc. Cumulatively, 9 reports have been recorded. Split: 0 buy · 2 sells. Total volume traded: €256k. History available since 30 November 2021. The latest transaction was disclosed on 28 November 2025 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Scots-Knight Denise
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations9 total
10,314 shares0Common StockSEC:0001297000-25-000006:0
18,169 shares0Common StockSEC:0001415889-24-028148:0
28,611 shares@ US$4.472745.1% of flowAmerican Depositary Shares representing Ordinary SharesSEC:0000950170-24-106976:0
188,060 shares0American Depositary Shares representing Ordinary SharesSEC:0000950170-24-106417:0
40,712 shares@ US$3.693954.9% of flowAmerican Depositary Shares representing Ordinary SharesSEC:0000950170-24-078465:0
282,090 shares0American Depositary Shares representing Ordinary SharesSEC:0000950170-24-077482:0
20,374 shares0Common StockSEC:0001415889-23-015778:0
18,649 shares0Common StockSEC:0001415889-22-011975:0
7,307 shares0Common StockSEC:0001179110-21-010523:0
9 of 9 declarations
About Scots-Knight Denise
Scots-Knight Denise is Administrateur at Elanco Animal Health Inc and Chief Executive Officer at Mereo BioPharma Group plc. The profile contains 9 filings in total, and across the 9 sampled filings between 2021-12-02 and 2025-12-02, sales total 255939 EUR, with the two largest reported for Mereo BioPharma Group plc at 140421.4778029626 EUR on 2024-06-27 and 115517.0947734423 EUR on 2024-09-16.
